Read what one of our Complex Nitrosamines Data Sharing Initiative members, Graham Smith, Oncology Chemical Toxicology Lead at AstraZeneca, has to say about being involved in this growing consortium!
Lhasa Limited is thrilled to announce the launch of Kaptis!
"Kaptis is an important tool for the development and interpretation of Integrated Approaches to Testing and Assessment for carcinogenicity" – Carole Yauk, Professor and Canada Research Chair in Genomics and the Environment.
In November last year, we published a ground-breaking article to Chemical Research in Toxicology titled ‘What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity Relationships’.
Within the paper, we show that certain structural features, when treated independently, have a statistically significant impact on the carcinogenic potency of nitrosamines. It is with great excitement that we share this publication making it to Chemical Research in Toxicology’s top 20 most downloaded articles, as well as being the most viewed article within their November edition.
Lhasa Limited is thrilled to announce the launch of Kaptis!
"Kaptis is an important tool for the development and interpretation of Integrated Approaches to Testing and Assessment for carcinogenicity" – Carole Yauk, Professor and Canada Research Chair in Genomics and the Environment.
In November last year, we published a ground-breaking article to Chemical Research in Toxicology titled ‘What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity Relationships’.
Within the paper, we show that certain structural features, when treated independently, have a statistically significant impact on the carcinogenic potency of nitrosamines. It is with great excitement that we share this publication making it to Chemical Research in Toxicology’s top 20 most downloaded articles, as well as being the most viewed article within their November edition.